Community-based provision of direct-acting antiviral therapy for hepatitis C: study protocol and challenges of a randomized controlled trial

BACKGROUND: To achieve the World Health Organization hepatitis C virus (HCV) elimination targets, it is essential to increase access to treatment. Direct-acting antiviral (DAA) treatment can be provided in primary healthcare services (PHCS), improving accessibility, and, potentially, retention in ca...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Trials
Main Authors: Wade, A. J., Doyle, J. S., Gane, E., Stedman, C., Draper, B., Iser, D., Roberts, S. K., Kemp, W., Petrie, D., Scott, N., Higgs, P., Agius, P. A., Roney, J., Stothers, L., Thompson, A. J., Hellard, M. E.
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2018
Assuntos:
Study Protocol
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6048874/
https://ncbi.nlm.nih.gov/pubmed/30012192
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13063-018-2768-3
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados